Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Securing the Supply Chain from Substandard and Falsified Drugs

FDA combines with international partners to create a new supply chain security toolkit that covers everything from raw materials to patient use.

“Keeping the U.S. Prescription Drug Supply Chain Among the Safest in the World,” was the headline of a July 20 blog by Ilisa Bernstein, Pharm.D., J.D., and Deputy Director of the Office of Compliance in FDA’s Center for Drug Evaluation and Research.

A story on the agency’s website explains that a global approach was taken to create a “Supply Chain Security Toolkit for Medical Products” that can serve as a resource for “industry stakeholders and regulators worldwide to adopt best practices, for training purposes, and to strengthen laws and regulations to protect consumers from unsafe and substandard drug products was the subject.”

FDA also referred to the tookit as “a roadmap to promote global medical product quality and supply chain security.” The tookit provides training materials in the following 10 categories:

• Good Manufacturing Practices

• Good Distribution Practices

• Good import/export practices

• Clinical/retail pharmacy practices

• Product security

• Detection technology

• Internet sales

• Track-and-trace systems

• Surveillance and monitoring

• Single points of contact

In her blog, Bernstein noted, “Substandard and falsified drugs are global problems that need global solutions and global collaboration. We cannot solve these challenges alone and we at FDA are continually looking for ways to collaborate and learn from our regulatory counterparts around the world. … Together with our global partners, we will continue to combat supply chain problems as they arise and increase confidence in the legitimacy of the life-saving prescription drugs that patients rely on.”

 

 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report